Julio Sainz de Aja

COOBoostR: An Extreme Gradient Boosting-Based Tool for Robust Tissue or Cell-of-Origin Prediction of Tumors

P. Polak, H. Nakagawa, Kirsten Kübler, 2022, bioRxiv.

The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters

J. V. Falvo, T. Zwaka, A. García-Sastre, 2022, bioRxiv.

SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery

C. Yao, B. Stripp, J. Kolls, 2021, Cell Reports.

Nanog regulates Pou3f1 expression and represses anterior fate at the exit from pluripotency

B. Göttgens, W. Jawaid, C. Torroja, 2019 .